Pfe stock target price

Based on 6 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $42.55 with a high forecast of $53.00 and a low 

See Pfizer, Inc. (PFE) stock analyst estimates, including earnings and revenue, No. of Analysts, 8, 8, 9, 9 Growth Estimates, PFE, Industry, Sector, S&P 500  Pfizer Share Price, Pfizer Stock Price, Pfizer Ltd. Stock/Share prices, Pfizer Ltd. Live BSE/NSE, F&O Quote of Pfizer Ltd. with Historic price charts for NSE / BSE. 27 Mar 2020 Pfizer lost $28 billion in market capitalization in the week after the deal was announced. Its stock was one of the worst performers in the Dow  Learn about PFE with our data and independent analysis including price, star rating, valuation, dividends, Undervalued Dividend Payers From Our Ultimate Stock Pickers Our analysts discuss where they see value in their sectors today. 4 days ago The average price target is $42.125, which means analysts expect the stock to add by 25.33% over the next twelve months. That average ranking 

PFE Pfizer Inc. Stock Quote - FINVIZ.com

Pfizer (NYSE:PFE) price target set to $46.00 by JPMorgan ... Apr 19, 2019 · Today, JPMorgan Chase & Co. set its price target on Pfizer (NYSE:PFE) to $46.00 per share. There are 12 Hold Ratings, 7 Buy Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. PFE Price Target - ETF Channel Get the latest Zacks research report on PFE — FREE. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the ETF as far as deciding whether to continue to hold the stock.

PFE Price Target and Analyst Ratings (Pfizer) | MarketBeat

Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. why Pfizer Inc. [PFE] is a Good Choice for Investors After ... Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $42.54 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.50. Standpoint Research slashes price target on Pfizer Inc ... Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $42.07 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.50. Pfizer - 48 Year Stock Price History | PFE | MacroTrends

12 equities research analysts have issued 1-year target prices for Pfizer's stock. Their forecasts range from $36.00 to $53.00. On average, they anticipate Pfizer's stock price to reach $41.30 in the next twelve months. This suggests a possible upside of 22.8% from the stock's current price. View analysts' price targets for Pfizer.

Nov 09, 2019 · Pfizer Inc. analyst estimates by MarketWatch. View PFE revenue estimates and earnings estimates, as well as analyst recommendations. Pfizer, Inc. (PFE) Stock Price, Quote, History & News ...

Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering ...

Average analyst Pfizer price target 12-months out, presented by Holdings Channel. Home · Articles · Latest Filings · All Funds · Stocks Being Bought · Stocks Being For the Pfizer price target at the top of the page, we present the average 

Pfizer, Inc. (PFE) Dividends: Its History, Yield, Price ... In terms trailing twelve months of dividends issued, PFE has returned $8,043,000,000 US dollars -- more than 97.07% of public US dividend stocks. If you want to include this stock in your dividend portfolio, here are some dividend stocks that are NOT correlated with PFE that may be suitable potential portfolio mates: ORA, K, IRET, LINC and SWCH. Is Pfizer Inc. (PFE) Stock a Good Buy? - InvestorsObserver Pfizer Inc. stock is down -23.99% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives PFE stock a score of 28 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 1. PFE's rank also includes a long-term technical score of 36.